Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma Article

Lassman, Andrew B, Aldape, Kenneth D, Ansell, Peter J et al. (2019). Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma . JOURNAL OF NEURO-ONCOLOGY, 144(1), 205-210. 10.1007/s11060-019-03222-y

Open Access Industry Collaboration International Collaboration

cited authors

  • Lassman, Andrew B; Aldape, Kenneth D; Ansell, Peter J; Bain, Earle; Curran, Walter J; Eoli, Marica; French, Pim J; Kinoshita, Manabu; Looman, Jim; Mehta, Minesh; Muragaki, Yoshihiro; Narita, Yoshitaka; Ocampo, Christopher; Roberts-Rapp, Lisa; Song, Minghao; Vogelbaum, Michael A; Walenkamp, Annemiek ME; Wang, Tony JC; Zhang, Peixin; van den Bent, Martin J

sustainable development goals

authors

publication date

  • August 1, 2019

webpage

published in

keywords

  • Biomarker
  • CELL LUNG-CANCER
  • Clinical Neurology
  • Depatux-m
  • EGFR
  • EXPRESSION
  • GBM
  • IDH1
  • Life Sciences & Biomedicine
  • MUTATIONS
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology
  • Screening

Digital Object Identifier (DOI)

publisher

  • SPRINGER

start page

  • 205

end page

  • 210

volume

  • 144

issue

  • 1